Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Presca : Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual Developmental Disorders

NCT07495761 is registered in ClinicalTrials.gov with Groupe Hospitalier Mutualiste de Grenoble as lead sponsor.

NCT NCT07495761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07495761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Presca : Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual Developmental Disorders
Lead sponsor
Groupe Hospitalier Mutualiste de Grenoble
Phase
Observational
Overall status
Recruiting
Start date
February 4, 2026
Completion date
July 29, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder (asd), pain management